[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Transdermal Drug Delivery System Market Report 2017

January 2017 | 119 pages | ID: U535988A077EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Transdermal Drug Delivery System

Revenue, means the sales value of Transdermal Drug Delivery System

This report studies sales (consumption) of Transdermal Drug Delivery System in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Novartis AG
  • Johnson & Johnson
  • Mylan Pharmaceuticals, Inc
  • Boehringer Ingelheim GmbH
  • Biogel Technology, Inc.
  • Transdermal Technologies, Inc.
  • Skyepharma PLC
  • Watson Pharmaceuticals, Inc
  • 3M Company
  • Noven Pharmaceuticals, Inc
  • 4P Therapeutics, LLC
  • Echo Therapeutics, Inc
  • Transdermal Corp
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Electroporation
  • Radiofrequency
  • Iontophoresis
  • Microporation
  • Other
Split by applications, this report focuses on sales, market share and growth rate of Transdermal Drug Delivery System in each application, can be divided into
  • Central Nervous System (CNS)
  • Pain Management
  • Cardiovascular
  • Other
United States Transdermal Drug Delivery System Market Report 2017

1 TRANSDERMAL DRUG DELIVERY SYSTEM OVERVIEW

1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Classification of Transdermal Drug Delivery System
  1.2.1 Electroporation
  1.2.2 Radiofrequency
  1.2.3 Iontophoresis
  1.2.4 Microporation
  1.2.5 Other
1.3 Application of Transdermal Drug Delivery System
  1.3.1 Central Nervous System (CNS)
  1.3.2 Pain Management
  1.3.3 Cardiovascular
  1.3.4 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Transdermal Drug Delivery System (2011-2021)
  1.4.1 United States Transdermal Drug Delivery System Sales and Growth Rate (2011-2021)
  1.4.2 United States Transdermal Drug Delivery System Revenue and Growth Rate (2011-2021)

2 UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM COMPETITION BY MANUFACTURERS

2.1 United States Transdermal Drug Delivery System Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Transdermal Drug Delivery System Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Transdermal Drug Delivery System Average Price by Manufactures (2015 and 2016)
2.4 Transdermal Drug Delivery System Market Competitive Situation and Trends
  2.4.1 Transdermal Drug Delivery System Market Concentration Rate
  2.4.2 Transdermal Drug Delivery System Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Transdermal Drug Delivery System Sales and Market Share by States (2011-2016)
3.2 United States Transdermal Drug Delivery System Revenue and Market Share by States (2011-2016)
3.3 United States Transdermal Drug Delivery System Price by States (2011-2016)

4 UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Transdermal Drug Delivery System Sales and Market Share by Type (2011-2016)
4.2 United States Transdermal Drug Delivery System Revenue and Market Share by Type (2011-2016)
4.3 United States Transdermal Drug Delivery System Price by Type (2011-2016)
4.4 United States Transdermal Drug Delivery System Sales Growth Rate by Type (2011-2016)

5 UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Transdermal Drug Delivery System Sales and Market Share by Application (2011-2016)
5.2 United States Transdermal Drug Delivery System Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MANUFACTURERS PROFILES/ANALYSIS

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.1.2.1 Electroporation
    6.1.2.2 Radiofrequency
  6.1.3 Novartis AG Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.2.2.1 Electroporation
    6.2.2.2 Radiofrequency
  6.2.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Mylan Pharmaceuticals, Inc
  6.3.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.3.2.1 Electroporation
    6.3.2.2 Radiofrequency
  6.3.3 Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim GmbH
  6.4.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.4.2.1 Electroporation
    6.4.2.2 Radiofrequency
  6.4.3 Boehringer Ingelheim GmbH Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Biogel Technology, Inc.
  6.5.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.5.2.1 Electroporation
    6.5.2.2 Radiofrequency
  6.5.3 Biogel Technology, Inc. Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Transdermal Technologies, Inc.
  6.6.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.6.2.1 Electroporation
    6.6.2.2 Radiofrequency
  6.6.3 Transdermal Technologies, Inc. Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Skyepharma PLC
  6.7.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.7.2.1 Electroporation
    6.7.2.2 Radiofrequency
  6.7.3 Skyepharma PLC Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Watson Pharmaceuticals, Inc
  6.8.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.8.2.1 Electroporation
    6.8.2.2 Radiofrequency
  6.8.3 Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 3M Company
  6.9.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.9.2.1 Electroporation
    6.9.2.2 Radiofrequency
  6.9.3 3M Company Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Noven Pharmaceuticals, Inc
  6.10.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.10.2.1 Electroporation
    6.10.2.2 Radiofrequency
  6.10.3 Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 4P Therapeutics, LLC
6.12 Echo Therapeutics, Inc
6.13 Transdermal Corp

7 TRANSDERMAL DRUG DELIVERY SYSTEM MANUFACTURING COST ANALYSIS

7.1 Transdermal Drug Delivery System Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Drug Delivery System

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transdermal Drug Delivery System Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST (2016-2021)

11.1 United States Transdermal Drug Delivery System Sales, Revenue Forecast (2016-2021)
11.2 United States Transdermal Drug Delivery System Sales Forecast by Type (2016-2021)
11.3 United States Transdermal Drug Delivery System Sales Forecast by Application (2016-2021)
11.4 Transdermal Drug Delivery System Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Drug Delivery System
Table Classification of Transdermal Drug Delivery System
Figure United States Sales Market Share of Transdermal Drug Delivery System by Type in 2015
Figure Electroporation Picture
Figure Radiofrequency Picture
Figure Iontophoresis Picture
Figure Microporation Picture
Figure Other Picture
Table Application of Transdermal Drug Delivery System
Figure United States Sales Market Share of Transdermal Drug Delivery System by Application in 2015
Figure Central Nervous System (CNS) Examples
Figure Pain Management Examples
Figure Cardiovascular Examples
Figure Other Examples
Figure United States Transdermal Drug Delivery System Sales and Growth Rate (2011-2021)
Figure United States Transdermal Drug Delivery System Revenue and Growth Rate (2011-2021)
Table United States Transdermal Drug Delivery System Sales of Key Manufacturers (2015 and 2016)
Table United States Transdermal Drug Delivery System Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Transdermal Drug Delivery System Sales Share by Manufacturers
Figure 2016 Transdermal Drug Delivery System Sales Share by Manufacturers
Table United States Transdermal Drug Delivery System Revenue by Manufacturers (2015 and 2016)
Table United States Transdermal Drug Delivery System Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Transdermal Drug Delivery System Revenue Share by Manufacturers
Table 2016 United States Transdermal Drug Delivery System Revenue Share by Manufacturers
Table United States Market Transdermal Drug Delivery System Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Transdermal Drug Delivery System Average Price of Key Manufacturers in 2015
Figure Transdermal Drug Delivery System Market Share of Top 3 Manufacturers
Figure Transdermal Drug Delivery System Market Share of Top 5 Manufacturers
Table United States Transdermal Drug Delivery System Sales by States (2011-2016)
Table United States Transdermal Drug Delivery System Sales Share by States (2011-2016)
Figure United States Transdermal Drug Delivery System Sales Market Share by States in 2015
Table United States Transdermal Drug Delivery System Revenue and Market Share by States (2011-2016)
Table United States Transdermal Drug Delivery System Revenue Share by States (2011-2016)
Figure Revenue Market Share of Transdermal Drug Delivery System by States (2011-2016)
Table United States Transdermal Drug Delivery System Price by States (2011-2016)
Table United States Transdermal Drug Delivery System Sales by Type (2011-2016)
Table United States Transdermal Drug Delivery System Sales Share by Type (2011-2016)
Figure United States Transdermal Drug Delivery System Sales Market Share by Type in 2015
Table United States Transdermal Drug Delivery System Revenue and Market Share by Type (2011-2016)
Table United States Transdermal Drug Delivery System Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Transdermal Drug Delivery System by Type (2011-2016)
Table United States Transdermal Drug Delivery System Price by Type (2011-2016)
Figure United States Transdermal Drug Delivery System Sales Growth Rate by Type (2011-2016)
Table United States Transdermal Drug Delivery System Sales by Application (2011-2016)
Table United States Transdermal Drug Delivery System Sales Market Share by Application (2011-2016)
Figure United States Transdermal Drug Delivery System Sales Market Share by Application in 2015
Table United States Transdermal Drug Delivery System Sales Growth Rate by Application (2011-2016)
Figure United States Transdermal Drug Delivery System Sales Growth Rate by Application (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Mylan Pharmaceuticals, Inc Basic Information List
Table Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Biogel Technology, Inc. Basic Information List
Table Biogel Technology, Inc. Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogel Technology, Inc. Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Transdermal Technologies, Inc. Basic Information List
Table Transdermal Technologies, Inc. Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Transdermal Technologies, Inc. Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Skyepharma PLC Basic Information List
Table Skyepharma PLC Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Skyepharma PLC Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Watson Pharmaceuticals, Inc Basic Information List
Table Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table 3M Company Basic Information List
Table 3M Company Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3M Company Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table Noven Pharmaceuticals, Inc Basic Information List
Table Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
Table Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Sales Market Share (2011-2016)
Table 4P Therapeutics, LLC Basic Information List
Table Echo Therapeutics, Inc Basic Information List
Table Transdermal Corp Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Drug Delivery System
Figure Manufacturing Process Analysis of Transdermal Drug Delivery System
Figure Transdermal Drug Delivery System Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2015
Table Major Buyers of Transdermal Drug Delivery System
Table Distributors/Traders List
Figure United States Transdermal Drug Delivery System Production and Growth Rate Forecast (2016-2021)
Figure United States Transdermal Drug Delivery System Revenue and Growth Rate Forecast (2016-2021)
Table United States Transdermal Drug Delivery System Production Forecast by Type (2016-2021)
Table United States Transdermal Drug Delivery System Consumption Forecast by Application (2016-2021)
Table United States Transdermal Drug Delivery System Sales Forecast by States (2016-2021)
Table United States Transdermal Drug Delivery System Sales Share Forecast by States (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories